| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| Cyclooxygenase (COX)-2 overexpression has been noted in various cancers.
PI3Ks/AKT pathways are over-activated in several types of cancers. EGFR altered activity has been noted in various pathological conditions. However, its regulation is an important step in the inhibition of cancer. In this regard, EGCG shows a pivotal role in the inhibition of EGFR activity. Activating protein-1 transcription factor has been associated with pathogenesis including cancer. Activation of the sonic hedgehog (Shh) pathway is required for the growth of numerous tissues and organs and recent evidence indicates that this pathway is often recruited to stimulate growth of cancer stem cells (CSCs) and to orchestrate the reprogramming of cancer cells via epithelial mesenchymal transition (EMT). Increased expression of Nanog has been associated with the aggressive nature of certain cancers, highlighting its role in promoting cancer stem cell characteristics. The aberrant hedgehog (Hh)/GLI signaling pathway causes the formation and progression of a variety of tumors. The process of cell apoptosis is often accompanied by the destruction of mitochondrial transmembrane potential, which is widely regarded as one of the earliest events in the process of cell apoptosis. Human malignancies frequently exhibit mutations in the TGF-β pathway, and overactivation of this system is linked to tumor growth by promoting angiogenesis and inhibiting the innate and adaptive antitumor immune responses50. Several studies have demonstrated that high cyclin D1 expression was observed in cancers including breast, lung, prostate, lymph node and colorectal cancers [23–25]. The oncogene c-myc, which is frequently over-expressed in cancer cells, is involved in the transactivation of most of the glycolytic enzymes including lactate dehydrogenase A (LDHA) and the glucose transporter GLUT1 [51,52]. Thus, c-myc activation is a likely candidate to promote the enhanced glucose uptake and lactate release in the proliferating cancer cell. Vimentin is overexpressed in various epithelial cancers, including prostate cancer, gastrointestinal tumors, tumors of the central nervous system, breast cancer, malignant melanoma, and lung cancer. Vimentin’s overexpression in cancer correlates well with accelerated tumor growth, invasion, and poor prognosis; however, the role of vimentin in cancer progression remains obscure. Heat shock proteins (HSPs) are normally induced under environmental stress to serve as chaperones for maintenance of correct protein folding but they are often overexpressed in many cancers, including breast cancer. Since NQO1 is highly expressed in many solid tumors, including via upregulation of Nrf2, the design of compounds activated by NQO1 and NQO1-targeted drug delivery have been active areas of research. Since increased Nrf2 gene expression is one of the main mechanisms of cancer cells in resisting chemotherapeutic drugs and survival in oxidative conditions; finding compounds with the ability to suppress Nrf2 gene expression with minimum side effects can be considered an important strategy for increasing the sensitivity of cancer cells to chemotherapy. Overexpression of c-met stimulates proliferation, migration and invasion in various types of cancer including prostate cancer. Overexpression of TGFα and EGFR by many carcinomas correlates with the development of cancer metastasis, resistance to chemotherapy and poor prognosis. More than 50% of human cancers have a mutated nonfunctional p53. |
| 5270- | 5-ALA, | PDT, | 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy |
| - | Review, | Var, | NA |
| 5462- | AF, | Repurposing Auranofin for Oncology and Beyond: A Brief Overview of Clinical Trials as Mono- and Combination Therapy |
| - | Review, | Var, | NA |
| 5470- | AF, | Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin |
| - | Review, | Var, | NA |
| 5444- | AG, | A Systematic Review of Phytochemistry, Pharmacology and Pharmacokinetics on Astragali Radix: Implications for Astragali Radix as a Personalized Medicine |
| - | Review, | Var, | NA |
| 5435- | AG, | Efficacy of Astragalus Membranaceus (Huang Qi) for Cancer-Related Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Studies |
| - | Review, | Var, | NA |
| 2666- | AL, | Targeting the Interplay of Autophagy and ROS for Cancer Therapy: An Updated Overview on Phytochemicals |
| - | Review, | Var, | NA |
| 5320- | ALC, | l-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer |
| - | in-vivo, | Var, | NA |
| 5324- | ALC, | The anti-wasting effects of L-carnitine supplementation on cancer: experimental data and clinical studies |
| - | Review, | Var, | NA |
| 5321- | ALC, | L-Carnitine |
| - | Review, | Var, | NA |
| 5319- | ALC, | l-carnitine and cancer cachexia: Clinical and experimental aspects |
| - | Review, | Var, | NA |
| 5382- | ART/DHA, | A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies |
| - | Trial, | Var, | NA |
| 5396- | Ash, | Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology |
| - | Review, | Var, | NA |
| 3155- | Ash, | Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera |
| - | Review, | Var, | NA |
| 2001- | Ash, | Withania somnifera: from prevention to treatment of cancer |
| - | Review, | Var, | NA |
| 5427- | ASTX, | Astaxanthin and Cancer Chemoprevention |
| - | Review, | Var, | NA |
| 5366- | AV, | Aloe vera: A review of toxicity and adverse clinical effects |
| - | Review, | Var, | NA |
| 5367- | AV, | Rad, | Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial |
| - | Trial, | Var, | NA |
| 5570- | B-Gluc, | Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1 |
| - | Review, | Var, | NA |
| 5567- | B-Gluc, | Trained immunity: A new player in cancer immunotherapy |
| - | Review, | Var, | NA |
| 2605- | Ba, | BA, | Potential therapeutic effects of baicalin and baicalein |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | IBD, | NA | - | Review, | Arthritis, | NA | - | Review, | AD, | NA | - | Review, | Park, | NA |
| 5631- | BCA, | Perspectives Regarding the Role of Biochanin A in Humans |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 5518- | BEV, | Chemo, | Bevacizumab |
| - | Review, | Var, | NA | - | Review, | AMD, | NA |
| 5680- | BML, | Anticancer properties of bromelain: State-of-the-art and recent trends |
| - | Review, | Var, | NA |
| 5682- | BML, | A novel treatment of bromelain and acetylcysteine (BromAc) in patients with peritoneal mucinous tumours: A phase I first in man study |
| - | Human, | Var, | NA |
| 696- | Bor, | Nothing Boring About Boron |
| - | Review, | Var, | NA |
| 4619- | Bor, | Using Boron Supplementation in Cancer Prevention and Treatment: A Review Article |
| - | Review, | Var, | NA |
| 2775- | Bos, | The journey of boswellic acids from synthesis to pharmacological activities |
| - | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | PSA, | NA |
| 5744- | Buty, | PacT, | Oral sodium butyrate supplementation ameliorates paclitaxel-induced behavioral and intestinal dysfunction |
| - | in-vivo, | Var, | NA |
| 5736- | Buty, | Clinical and pharmacologic study of tributyrin: an oral butyrate prodrug |
| - | Trial, | Var, | NA |
| 5827- | CAP, | The Effect of Topical Capsaicin 8% on Pain in Chemotherapy-induced Peripheral Neuropathy |
| - | Trial, | Var, | NA |
| 5894- | CAR, | Targeting Gastrointestinal Cancers with Carvacrol: Mechanistic Insights and Therapeutic Potential |
| - | Review, | Var, | NA |
| 5918- | Cats, | Uncaria tomentosa (cat's claw) improves quality of life in patients with advanced solid tumors |
| - | Trial, | Var, | NA |
| 5813- | CBD, | Pharmacokinetics of Cannabidiol: A Systematic Review and Meta-Regression Analysis |
| - | Review, | Var, | NA |
| 6001- | Chit, | Recent advances in engineering chitosan-based nanoplatforms in biotherapeutic multi-delivery for multi-targeted disease treatments: Promises and outlooks |
| - | Review, | Var, | HepG2 | - | Review, | AD, | NA |
| 2806- | CHr, | Se, | Selenium-containing chrysin and quercetin derivatives: attractive scaffolds for cancer therapy |
| - | in-vitro, | Var, | NA |
| 2784- | CHr, | Chrysin targets aberrant molecular signatures and pathways in carcinogenesis (Review) |
| - | Review, | Var, | NA |
| 4768- | CoQ10, | Role of coenzymes in cancer metabolism |
| - | Review, | Var, | NA |
| 3590- | CUR, | The Holy Grail of Curcumin and its Efficacy in Various Diseases: Is Bioavailability Truly a Big Concern? |
| - | Review, | Var, | NA | - | Review, | AD, | NA |
| 1863- | dietFMD, | Chemo, | Effect of fasting on cancer: A narrative review of scientific evidence |
| - | Review, | Var, | NA |
| 1841- | dietFMD, | Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer |
| - | Trial, | Var, | NA |
| 5065- | dietSTF, | dietFMD, | Nutrition, GH/IGF-I Signaling, and Cancer |
| - | Review, | Var, | NA |
| 5069- | dietSTF, | The Role of Intermittent Fasting in the Activation of Autophagy Processes in the Context of Cancer Diseases |
| - | Review, | Var, | NA |
| 4914- | DSF, | immuno, | Disulfiram and cancer immunotherapy: Advanced nano-delivery systems and potential therapeutic strategies |
| - | Review, | Var, | NA |
| 4916- | DSF, | Cu, | The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics |
| - | Review, | Var, | NA |
| 1605- | EA, | Ellagic Acid and Cancer Hallmarks: Insights from Experimental Evidence |
| - | Review, | Var, | NA |
| 5525- | EP, | Cell responses without receptors and ligands, using nanosecond pulsed electric fields (nsPEFs) |
| - | Review, | Var, | NA |
| 5519- | EP, | Nanosecond Pulsed Electric Fields (nsPEFs) for Precision Intracellular Oncotherapy: Recent Advances and Emerging Directions |
| - | Review, | Var, | NA |
| 2145- | Ex, | Leisure time physical activity and cancer risk: evaluation of the WHO's recommendation based on 126 high-quality epidemiological studies |
| - | Analysis, | Var, | NA |
| 2150- | Ex, | Roles and molecular mechanisms of physical exercise in cancer prevention and treatment |
| - | Review, | Var, | NA |
| 2827- | FIS, | The Potential Role of Fisetin, a Flavonoid in Cancer Prevention and Treatment |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:26 Cells:% prod#:% Target#:1114 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid